Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
November-December 2013 Volume 1 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-December 2013 Volume 1 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation

  • Authors:
    • Fenxi Zhang
    • Ming Lu
    • Huaibin Wang
    • Tongming Ren
  • View Affiliations / Copyright

    Affiliations: Department of Anatomy, Sanquan College, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China
  • Pages: 930-934
    |
    Published online on: August 23, 2013
       https://doi.org/10.3892/br.2013.160
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Angiotensin II (Ang II) is a peptide hormone that plays a critical role in numerous physiological and pathophysiological processes. It is also commonly used as an inducer for the directional differentiation of bone marrow mesenchymal stem cells (bmMSCs). Previous studies demonstrated that Ang II induces inflammatory responses in endothelial cells, smooth muscle cells and fibroblasts. Aspirin is generally used as analgesic, antipyretic and occasionally anti‑inflammatory medication. Whether aspirin suppresses inflammatory responses in bmMSCs has not been elucidated. In this study, we investigated the effect of aspirin on Ang II‑induced inflammation in bmMSCs. Our results demonstrated that Ang II (10 nM‑10 µM) increased the secretion of tumor necrosis factor (TNF)‑α and interleukin (IL)‑6 from bmMSCs in a dose‑dependent manner. This result was further confirmed by a reverse transcription‑polymerase chain reaction (RT‑PCR) assay, which demonstrated a dose‑dependent increase in the mRNA expression of TNF‑α, IL‑6, IL‑1β and monocyte chemotactic protein‑1 (MCP‑1) in bmMSCs following exposure to Ang II. Furthermore, it was also observed that Ang II increased the expression of phospho‑extracellular signal‑regulated kinase 1/2 (ERK1/2) and phospho‑nuclear factor κ‑light‑chain‑enhancer of activated B cells (NF‑κB)‑p65 in bmMSCs. The application of aspirin (0.1 mM) significantly inhibited the activation of ERK1/2 and NF‑κB, the expression of TNF‑α, IL‑6, IL‑1β and MCP‑1 genes and the secretion of TNF‑α and IL‑6. Our findings indicated that aspirin may attenuate Ang II‑induced inflammation in bmMSCs via the inhibition of ERK1/2 and NF‑κB activation.
View Figures

Figure 1

Figure 2

View References

1 

Rostovskaya M and Anastassiadis K: Differential expression of surface markers in mouse bone marrow mesenchymal stromal cell subpopulations with distinct lineage commitment. PLoS One. 7:e512212012. View Article : Google Scholar

2 

Jackson L, Jones DR, Scotting P, et al: Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med. 53:121–127. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Mehta PK and Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 292:C82–C97. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Xing Y, Lv A, Wang L, et al: The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol Cell Biochem. 360:279–287. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Matsushita K, Wu Y, Okamoto Y, et al: Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension. 48:1095–1102. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Kim YM, Jeon ES, Kim MR, et al: Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells. Int J Biochem Cell Biol. 40:2482–2491. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Zhan Y, Brown C, Maynard E, et al: Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest. 115:2508–2516. 2005. View Article : Google Scholar

8 

Wang X, Lu J, Khaidakov M, et al: Aspirin suppresses cardiac fibroblast proliferation and collagen formation through downregulation of angiotensin type 1 receptor transcription. Toxicol Appl Pharmacol. 259:346–354. 2012. View Article : Google Scholar

9 

Wolak T, Kim H, Ren Y, et al: Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int. 76:32–43. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Chen JW, Zhou SB and Tan ZM: Aspirin and pravastatin reduce lectin-like oxidized low density lipoprotein receptor-1 expression, adhesion molecules and oxidative stress in human coronary artery endothelial cells. Chin Med J (Engl). 123:1553–1556. 2010.

11 

Wu Y, Zhai H, Wang Y, et al: Aspirin-triggered lipoxin A4attenuates lipopolysaccharide-induced intracellular ROS in BV2 microglia cells by inhibiting the function of NADPH oxidase. Neurochem Res. 37:1690–1696. 2012.

12 

Zhang F, Wang C, Jing S, et al: Lectin-like oxidized LDL receptor-1 expresses in mouse bone marrow-derived mesenchymal stem cells and stimulates their proliferation. Exp Cell Res. 319:1054–1059. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Zhang F, Jing S, Ren T, et al: microRNA-10b promotes the migration of mouse bone marrow-derived mesenchymal stem cells and downregulates the expression of E-cadherin. Mol Med Rep. Aug 6–2013.(Epub ahead of print). View Article : Google Scholar

14 

van Velthoven CT, Kavelaars A and Heijnen CJ: Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr Res. 71:474–481. 2012.PubMed/NCBI

15 

Pastore S, Mascia F, Mariotti F, et al: ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol. 174:5047–5056. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Lee WK, Chung KW, Kim GH, et al: Gallotannin causes differentiation and inflammation via ERK-1/-2 and p38 kinase pathways in rabbit articular chondrocytes. Mol Med Rep. 7:701–707. 2013.PubMed/NCBI

17 

Vartiainen N, Goldsteins G, Keksa-Goldsteine V, et al: Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage. Stroke. 34:752–757. 2003. View Article : Google Scholar

18 

Wang YP, Wu Y, Li LY, et al: Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells. J Neuroinflammation. 8:952011.PubMed/NCBI

19 

Ke X, Chen J, Zhang X, et al: Qing Hua Chang Yin attenuates lipopolysaccharide-induced inflammatory response in human intestinal cells by inhibiting NF-κB activation. Exp Ther Med. 6:189–193. 2013.PubMed/NCBI

20 

Yamamoto Y and Gaynor RB: Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest. 107:135–142. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Muller DN, Heissmeyer V, Dechend R, et al: Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. FASEB J. 15:1822–1824. 2001.PubMed/NCBI

22 

Akyazi I, Eraslan E, Gulcubuk A, et al: Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats. World J Gastroenterol. 19:2894–2903. 2013.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang F, Lu M, Wang H and Ren T: Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation. Biomed Rep 1: 930-934, 2013.
APA
Zhang, F., Lu, M., Wang, H., & Ren, T. (2013). Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation. Biomedical Reports, 1, 930-934. https://doi.org/10.3892/br.2013.160
MLA
Zhang, F., Lu, M., Wang, H., Ren, T."Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation". Biomedical Reports 1.6 (2013): 930-934.
Chicago
Zhang, F., Lu, M., Wang, H., Ren, T."Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation". Biomedical Reports 1, no. 6 (2013): 930-934. https://doi.org/10.3892/br.2013.160
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang F, Lu M, Wang H and Ren T: Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation. Biomed Rep 1: 930-934, 2013.
APA
Zhang, F., Lu, M., Wang, H., & Ren, T. (2013). Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation. Biomedical Reports, 1, 930-934. https://doi.org/10.3892/br.2013.160
MLA
Zhang, F., Lu, M., Wang, H., Ren, T."Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation". Biomedical Reports 1.6 (2013): 930-934.
Chicago
Zhang, F., Lu, M., Wang, H., Ren, T."Aspirin attenuates angiotensin II‑induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF‑κB activation". Biomedical Reports 1, no. 6 (2013): 930-934. https://doi.org/10.3892/br.2013.160
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team